Covid-19 Treatment Approval To Drive Eli Lilly Stock Higher?
- Wednesday, November 18, 2020, 8:55
- Market
- Add a comment
Eli Lilly & Company stock is up 7% since the start of the year and it has gained around 19% from its March lows. LLY stock could offer an upside in the near term, as the company’s revenues in the last two quarters have grown by 1%. The current pandemic has resulted in an increased demand for covid..
About the Author
admin123 has written 23415 stories on this site.
